Why is Gland Pharma falling/rising?

As of 04-Sep, Gland Pharma Ltd's stock price is currently at 1,880.70, reflecting a decrease of 3.85 points or 0.2%. The stock's performance today is in line with the sector, but it is experiencing a decline in investor participation, with delivery volume falling by 67.39% compared to the 5-day average. Over the past week, the stock has shown a slight increase of 0.06%, but it has declined by 5.07% over the past month. Despite a year-to-date gain of 5.15%, the stock has underperformed over the last three years, dropping 26.71% compared to the benchmark's gain of 37.27%. The company maintains a low debt-to-equity ratio and has reported strong financial results, including record net sales and profit before tax, which may support its valuation. In the broader market context, the Sensex has risen by 0.80% over the past week, indicating a stronger performance compared to Gland Pharma's slight increase. The stock's recent decline could be attributed to the significant drop in delivery volumes, suggesting reduced investor interest, despite high institutional holdings at 40.24%, which typically indicates confidence in the company's fundamentals. The stock's moving averages show it is performing better than the 100-day and 200-day averages but worse than the shorter-term averages, indicating mixed sentiment among investors. Overall, while Gland Pharma has solid fundamentals, the recent price movement reflects a combination of declining investor participation and broader market dynamics.